Alphamab Oncology (HKG:9966)
7.52
-0.04 (-0.53%)
Jul 30, 2026, 2:12 PM HKT
Alphamab Oncology Employees
Alphamab Oncology had 498 employees as of December 31, 2025. The number of employees increased by 78 or 18.57% compared to the previous year.
Employees
498
Change (1Y)
78
Growth (1Y)
18.57%
Revenue / Employee
1.27M HKD
Profits / Employee
-254.60K HKD
Market Cap
7.32B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 498 | 78 | 18.57% |
| Dec 31, 2024 | 420 | -15 | -3.45% |
| Dec 31, 2023 | 435 | -37 | -7.84% |
| Dec 31, 2022 | 472 | 13 | 2.83% |
| Dec 31, 2021 | 459 | 125 | 37.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,110 |
| Everest Medicines | 812 |
| Lepu Biopharma | 710 |
| Suzhou Ribo Life Science | 407 |
| CARsgen Therapeutics Holdings | 355 |
| Abbisko Cayman | 276 |
| CStone Pharmaceuticals | 136 |
Alphamab Oncology News
- 7 months ago - Alphamab Oncology's JSKN033 Cleared For Phase 2 Cervical Cancer Trial By Chinese Regulatory Agency - Nasdaq